Patient Home Monitoring Corp. has raised $73M over 23 rounds; too few niche peers to rank its valuation yet.
Raised $73M across 23 disclosed rounds, last modeled as Recurring offerings.
Valued on the healthtech profile — its sector's growth and survival benchmarks differ from the market default, so the same raise is worth more or less here.
Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
Latest round stepped up 16.5× from the prior — scaling.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Program ended
Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
For a recurring offering issuer, long silence usually means the offering program is inactive or ended; it is not proof the legal entity is defunct.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Recurring offering issuermedium confidence
Patient Home Monitoring Corp. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
12.8 yr record
Peak capital year was 2015 with $54.0M across 11 filings.
Market position
ahead of 94% of Healthtech peers
Capital scale is ahead of 94% of Healthtech peers; modeled value is above 80% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
23 dated financing filings, averaging about 4 months apart.
No clearly named CEO/founder/principal role in the public records surfaced here.
No verified homepage on the profile yet.
Capital program peaked in 2015: $54.0M across 11 filings.
Largest single filing was $39.7M on 2015-07-10.
How to read the page
Read this less like a startup funding journey and more like a capital-raising program.
Stage-based valuation and peer labels have lower applicability for this pattern.
The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Where it sits in Healthtech
Patient Home Monitoring Corp. is one of 2138 Healthtech companies tracked from WILDER. By capital raised it ranks among the largest (ahead of 94% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
healthtech
As reported in public records reported — not modeled.
US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2020-06-29
First sale
Amount raised vs valuation, by year
This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.
Annual capital raised · realLatest value in year · estCumulative funded · real
Dense history compressed: 23 filings shown as 6 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Financing ladder & sequence gaps
This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.
Initial offering$168K · 2013
Follow-on offering$689K · 2013
Follow-on offering$1.5M · 2014
Follow-on offering$140K · 2014
Follow-on offering$129K · 2014
Follow-on offering$2.4M · 2014
Follow-on offering$1.0M · 2014
Follow-on offering$2.4M · 2015
Follow-on offering$3.2M · 2015
Follow-on offering$3.3M · 2015
Follow-on offering$1.2M · 2015
Follow-on offering$557K · 2015
Follow-on offering$1.5M · 2015
Follow-on offering$39.7M · 2015
Follow-on offering$246K · 2015
Follow-on offering$200K · 2015
Follow-on offering$276K · 2015
Follow-on offering$1.3M · 2015
Follow-on offering$118K · 2016
Follow-on offering$349K · 2016
Follow-on offering$7.0M · 2016
Follow-on offering$286K · 2017
Follow-on offering$4.7M · 2020
Modeled valuation trajectory
$116.9M
Base estimate est.
$11.1M
Conservative case
$450.0M
Upside case
$26.2M
Modeled post-money
This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$10.6M/yr
Capital velocity
12.8 yr
On record since
2013
First round
23
Rounds on file
How it compares to the market
Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Total raised — vs sector median (real $, all stages)▲ 16× above median
This company$72.5M
Sector median$4.5M
Modeled value — vs sector median (estimate, all stages)▲ 3.5× above median
This company$116.9M
Sector median$33.8M
Raised more than 94% of sector peers (real $). Modeled value above 80% of peers (estimate).
Full financing history
This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.
Stage
Amount · real
Announced
Post-money · est
Value · est
Conf.
Initial offering
$168K
2013-09-06
$936K
$5.8M
85%
Follow-on offering
$689K
2013-09-20
$3.8M
$23.8M
85%
Follow-on offering
$1.5M
2014-06-03
$7.4M
$40.8M
90%
Follow-on offering
$140K
2014-06-26
$702K
$3.9M
90%
Follow-on offering
$129K
2014-08-27
$643K
$3.6M
85%
Follow-on offering
$2.4M
2014-10-01
$10.9M
$54.0M
90%
Follow-on offering
$1.0M
2014-12-04
$4.6M
$23.0M
90%
Follow-on offering
$2.4M
2015-01-19
$10.7M
$53.4M
85%
Follow-on offering
$3.2M
2015-03-18
$14.8M
$73.3M
90%
Follow-on offering
$3.3M
2015-03-30
$14.9M
$74.1M
90%
Follow-on offering
$1.2M
2015-04-14
$5.5M
$27.5M
90%
Follow-on offering
$557K
2015-05-04
$2.5M
$12.6M
85%
Follow-on offering
$1.5M
2015-06-01
$8.5M
$38.0M
90%
Follow-on offering
$39.7M
2015-07-10
$220.8M
$985.1M
90%
Follow-on offering
$246K
2015-07-22
$1.4M
$6.1M
85%
Follow-on offering
$200K
2015-08-04
$1.1M
$5.0M
90%
Follow-on offering
$276K
2015-10-09
$1.5M
$6.8M
85%
Follow-on offering
$1.3M
2015-10-30
$7.2M
$32.2M
85%
Follow-on offering
$118K
2016-01-15
$658K
$2.9M
85%
Follow-on offering
$349K
2016-03-10
$1.9M
$8.7M
85%
Follow-on offering
$7.0M
2016-04-19
$39.2M
$174.7M
85%
Follow-on offering
$286K
2017-01-03
$1.6M
$7.1M
90%
Follow-on offering
$4.7M
2020-06-29
$26.2M
$116.9M
90%
What happened at each round
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Initial offering$168K2013-09-06
First recorded raise — entered as Initial offering.
2 investors on this round.
Follow-on offering$689K2013-09-20
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 4.1× larger than the prior — scaling up.
3 investors on this round.
Follow-on offering$1.5M2014-06-03
Raised 8 mo later, in step with the ~14 mo sector norm.
Round 2.1× larger than the prior — scaling up.
3 investors on this round.
Follow-on offering$140K2014-06-26
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 10.5× smaller than the prior — bridge or down round.
1 investor on this round.
Follow-on offering$129K2014-08-27
Came back fast: 2 mo vs the ~14 mo sector norm.
Round roughly the size of the prior one.
1 investor on this round.
Follow-on offering$2.4M2014-10-01
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 18.6× larger than the prior — scaling up.
4 investors on this round.
Follow-on offering$1.0M2014-12-04
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 2.4× smaller than the prior — bridge or down round.
2 investors on this round.
Follow-on offering$2.4M2015-01-19
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 2.3× larger than the prior — scaling up.
2 investors on this round.
Follow-on offering$3.2M2015-03-18
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 1.4× larger than the prior — scaling up.
2 investors on this round.
Follow-on offering$3.3M2015-03-30
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
5 investors on this round.
Follow-on offering$1.2M2015-04-14
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 2.7× smaller than the prior — bridge or down round.
1 investor on this round.
Follow-on offering$557K2015-05-04
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 2.2× smaller than the prior — bridge or down round.
1 investor on this round.
Follow-on offering$1.5M2015-06-01
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 2.7× larger than the prior — scaling up.
3 investors on this round.
Follow-on offering$39.7M2015-07-10
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 26.0× larger than the prior — scaling up.
4 investors on this round.
Follow-on offering$246K2015-07-22
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 161.4× smaller than the prior — bridge or down round.
1 investor on this round.
Follow-on offering$200K2015-08-04
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
1 investor on this round.
Follow-on offering$276K2015-10-09
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 1.4× larger than the prior — scaling up.
1 investor on this round.
Follow-on offering$1.3M2015-10-30
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 4.7× larger than the prior — scaling up.
2 investors on this round.
Follow-on offering$118K2016-01-15
Came back fast: 3 mo vs the ~14 mo sector norm.
Round 11.0× smaller than the prior — bridge or down round.
1 investor on this round.
Follow-on offering$349K2016-03-10
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 2.9× larger than the prior — scaling up.
1 investor on this round.
Follow-on offering$7.0M2016-04-19
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 20.2× larger than the prior — scaling up.
6 investors on this round.
Follow-on offering$286K2017-01-03
Raised 9 mo later, in step with the ~14 mo sector norm.
Round 24.6× smaller than the prior — bridge or down round.
2 investors on this round.
Follow-on offering$4.7M2020-06-29
Raised again after 42 mo — slower than the ~14 mo sector norm.
Round 16.5× larger than the prior — scaling up.
3 investors on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~4mo cadence
$14.2M
Modeled next size est.range $9.2M–$22.6M
16.5×
Last step-up
$10.6M/yr
Capital velocity
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Key people & operators
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
Patient Home Monitoring Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
United States
Country of record
US
Jurisdiction
1540013
SEC CIK
Similar companies
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
How much funding has Patient Home Monitoring Corp. raised?
Patient Home Monitoring Corp. has raised approximately $72.5M in disclosed capital across 23 recorded financing rounds, aggregated from public filings.
What is Patient Home Monitoring Corp.'s estimated valuation?
Provath's modeled valuation for Patient Home Monitoring Corp. is approximately $116.9M (modeled range $11.1M–$450.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Patient Home Monitoring Corp. at?
Patient Home Monitoring Corp. shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Mon Jun 29.
What does Patient Home Monitoring Corp. do and where is it based?
Patient Home Monitoring Corp. operates in the Healthtech sector, based in WILDER.
Explore related
See where Patient Home Monitoring Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Patient Home Monitoring Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.